Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells.

Lee SB, Seo D, Choi D, Park KY, Holczbauer A, Marquardt JU, Conner EA, Factor VM, Thorgeirsson SS.

Stem Cells. 2012 May;30(5):997-1007. doi: 10.1002/stem.1074.

2.

Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.

Wang J, Zhao P, Wan Z, Jin X, Cheng Y, Yan T, Qing S, Ding N, Xin S.

Cell Biochem Funct. 2016 Oct;34(7):475-482. doi: 10.1002/cbf.3210. Epub 2016 Aug 29.

PMID:
27569862
3.

Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.

Sommer CA, Christodoulou C, Gianotti-Sommer A, Shen SS, Sailaja BS, Hezroni H, Spira A, Meshorer E, Kotton DN, Mostoslavsky G.

PLoS One. 2012;7(12):e51711. doi: 10.1371/journal.pone.0051711. Epub 2012 Dec 14.

4.

Reprogramming to pluripotency through a somatic stem cell intermediate.

Marthaler AG, Tiemann U, Araúzo-Bravo MJ, Wu G, Zaehres H, Hyun JK, Han DW, Schöler HR, Tapia N.

PLoS One. 2013 Dec 27;8(12):e85138. doi: 10.1371/journal.pone.0085138. eCollection 2013.

5.

High efficient differentiation of functional hepatocytes from porcine induced pluripotent stem cells.

Ao Y, Mich-Basso JD, Lin B, Yang L.

PLoS One. 2014 Jun 20;9(6):e100417. doi: 10.1371/journal.pone.0100417. eCollection 2014.

6.

MicroRNAs contribute to induced pluripotent stem cell somatic donor memory.

Vitaloni M, Pulecio J, Bilic J, Kuebler B, Laricchia-Robbio L, Izpisua Belmonte JC.

J Biol Chem. 2014 Jan 24;289(4):2084-98. doi: 10.1074/jbc.M113.538702. Epub 2013 Dec 5.

7.

Aneuploidy is permissive for hepatocyte-like cell differentiation from human induced pluripotent stem cells.

Noto FK, Determan MR, Cai J, Cayo MA, Mallanna SK, Duncan SA.

BMC Res Notes. 2014 Jul 8;7:437. doi: 10.1186/1756-0500-7-437.

8.

Continuous passages accelerate the reprogramming of mouse induced pluripotent stem cells.

Shan ZY, Wu YS, Li X, Shen XH, Wang ZD, Liu ZH, Shen JL, Lei L.

Cell Reprogram. 2014 Feb;16(1):77-83. doi: 10.1089/cell.2013.0067. Epub 2014 Jan 4.

9.

Induction of pluripotent stem cells from a cynomolgus monkey using a polycistronic simian immunodeficiency virus-based vector, differentiation toward functional cardiomyocytes, and generation of stably expressing reporter lines.

Wunderlich S, Haase A, Merkert S, Beier J, Schwanke K, Schambach A, Glage S, Göhring G, Curnow EC, Martin U.

Cell Reprogram. 2012 Dec;14(6):471-84. doi: 10.1089/cell.2012.0041.

10.

The Construction and Identification of Induced Pluripotent Stem Cells Derived from Acute Myelogenous Leukemia Cells.

Zhu LF, Chen QR, Chen SZ, Wang LY, Luo XF, Ren JH, Yuan XH, Wu XQ, Zeng YL, Xiao M, Chen YQ, Chen YY, Lin MH, Wu ZJ, Chen ZZ, Hu JD, Yang T.

Cell Physiol Biochem. 2017;41(4):1661-1674. doi: 10.1159/000471246. Epub 2017 Mar 29.

11.

Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells.

Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, Natesan S, Wagers AJ, Melnick A, Evans T, Hochedlinger K.

Nat Biotechnol. 2010 Aug;28(8):848-55. doi: 10.1038/nbt.1667. Epub 2010 Jul 19.

12.

Derivation and characterization of induced pluripotent stem cells from equine fibroblasts.

Breton A, Sharma R, Diaz AC, Parham AG, Graham A, Neil C, Whitelaw CB, Milne E, Donadeu FX.

Stem Cells Dev. 2013 Feb 15;22(4):611-21. doi: 10.1089/scd.2012.0052. Epub 2012 Sep 28.

13.

Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy.

Eggenschwiler R, Loya K, Wu G, Sharma AD, Sgodda M, Zychlinski D, Herr C, Steinemann D, Teckman J, Bals R, Ott M, Schambach A, Schöler HR, Cantz T.

Stem Cells Transl Med. 2013 Sep;2(9):641-54. doi: 10.5966/sctm.2013-0017. Epub 2013 Aug 7.

14.

Generation of mouse induced pluripotent stem cells by protein transduction.

Nemes C, Varga E, Polgar Z, Klincumhom N, Pirity MK, Dinnyes A.

Tissue Eng Part C Methods. 2014 May;20(5):383-92. doi: 10.1089/ten.TEC.2013.0026. Epub 2013 Oct 12.

15.

In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins.

Liu H, Kim Y, Sharkis S, Marchionni L, Jang YY.

Sci Transl Med. 2011 May 11;3(82):82ra39. doi: 10.1126/scitranslmed.3002376.

16.

Induced pluripotent stem cells and hepatic differentiation.

Chiang CH, Huo TI, Sun CC, Hsieh JH, Chien Y, Lu KH, Lee SD.

J Chin Med Assoc. 2013 Nov;76(11):599-605. doi: 10.1016/j.jcma.2013.07.007. Epub 2013 Aug 9. Review.

17.

Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis.

Lee J, Kim Y, Yi H, Diecke S, Kim J, Jung H, Rim YA, Jung SM, Kim M, Kim YG, Park SH, Kim HY, Ju JH.

Arthritis Res Ther. 2014 Feb 4;16(1):R41. doi: 10.1186/ar4470.

18.

Genetic background affects induced pluripotent stem cell generation.

Schnabel LV, Abratte CM, Schimenti JC, Southard TL, Fortier LA.

Stem Cell Res Ther. 2012 Aug 3;3(4):30. doi: 10.1186/scrt121.

19.

Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.

Liu K, Ji G, Mao J, Liu M, Wang L, Chen C, Liu L.

Cell Reprogram. 2012 Dec;14(6):505-13. doi: 10.1089/cell.2012.0047. Epub 2012 Oct 4.

PMID:
23035653
20.

Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.

Jia B, Chen S, Zhao Z, Liu P, Cai J, Qin D, Du J, Wu C, Chen Q, Cai X, Zhang H, Yu Y, Pei D, Zhong M, Pan G.

Life Sci. 2014 Jul 11;108(1):22-9. doi: 10.1016/j.lfs.2014.05.004. Epub 2014 May 13.

PMID:
24834837

Supplemental Content

Support Center